Birdwatch Note
2024-01-17 13:08:16 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
代替医療にがんの治療効果がないことは既に明らかになっています https://doi.org/10.1093/jnci/djx145 https://doi.org/10.1001/jamaoncol.2018.2487 米国では1991年から国を挙げて30年以上研究してきましたが、がんに効果のある代替医療は未だに見つかっていません https://en.wikipedia.org/wiki/National_Center_for_Complementary_and_Integrative_Health 尚、米国国立がん研究所所長(当時)DeVita氏は、がん死亡減少の半分の原因は主に化学療法を含むがん治療の進歩によるものとしています https://doi.org/10.1158/0008-5472.CAN-07-6611 https://en.wikipedia.org/wiki/Vincent_T._DeVita 現在の主流のがん治療は劇的に進歩しています https://news.yahoo.co.jp/expert/articles/1b191a2ed5889e97d4311826f130aa016629b2a8 年齢調整死亡率で日本はG7の中でも最も優秀です https://data.oecd.org/chart/7hLT https://data.oecd.org/healthstat/deaths-from-cancer.htm 日本人が欧米事情等に疎いことは昔からデマに良く悪用されてきたので注意しましょう https://cancer.jpn.org/static/fake_medicine.html
Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1747463461918187892
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1747606767046132004
- noteId - 1747606767046132004
- participantId -
- noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
- createdAtMillis - 1705496896884
- tweetId - 1747463461918187892
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 代替医療にがんの治療効果がないことは既に明らかになっています https://doi.org/10.1093/jnci/djx145 https://doi.org/10.1001/jamaoncol.2018.2487 米国では1991年から国を挙げて30年以上研究してきましたが、がんに効果のある代替医療は未だに見つかっていません https://en.wikipedia.org/wiki/National_Center_for_Complementary_and_Integrative_Health 尚、米国国立がん研究所所長(当時)DeVita氏は、がん死亡減少の半分の原因は主に化学療法を含むがん治療の進歩によるものとしています https://doi.org/10.1158/0008-5472.CAN-07-6611 https://en.wikipedia.org/wiki/Vincent_T._DeVita 現在の主流のがん治療は劇的に進歩しています https://news.yahoo.co.jp/expert/articles/1b191a2ed5889e97d4311826f130aa016629b2a8 年齢調整死亡率で日本はG7の中でも最も優秀です https://data.oecd.org/chart/7hLT https://data.oecd.org/healthstat/deaths-from-cancer.htm 日本人が欧米事情等に疎いことは昔からデマに良く悪用されてきたので注意しましょう https://cancer.jpn.org/static/fake_medicine.html
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-01-17 13:08:16 UTC (1705496896884) |
2024-01-17 17:07:07 UTC (1705511227481) |
CURRENTLY_RATED_HELPFUL | 2024-01-18 02:16:30 UTC (1705544190408) |
CURRENTLY_RATED_HELPFUL | 2024-01-17 17:07:07 UTC (1705511227481) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-01-17 18:59:02 -0600 | Rating Details | |
| 2024-01-17 17:42:21 -0600 | Rating Details | |
| 2024-01-17 16:40:22 -0600 | Rating Details | |
| 2024-01-17 14:45:24 -0600 | Rating Details | |
| 2024-01-17 10:57:28 -0600 | Rating Details | |
| 2024-01-17 09:44:12 -0600 | Rating Details | |
| 2024-01-17 09:27:19 -0600 | Rating Details | |
| 2024-01-17 09:19:46 -0600 | Rating Details | |
| 2024-01-17 08:24:15 -0600 | Rating Details | |
| 2024-01-17 08:19:55 -0600 | Rating Details | |
| 2024-01-17 08:07:20 -0600 | Rating Details | |
| 2024-01-17 08:00:35 -0600 | Rating Details | |
| 2024-01-17 07:59:06 -0600 | Rating Details | |
| 2024-01-17 07:56:36 -0600 | Rating Details | |
| 2024-01-17 07:56:07 -0600 | Rating Details | |
| 2024-01-17 07:52:55 -0600 | Rating Details | |
| 2024-01-17 07:46:38 -0600 | Rating Details | |
| 2024-01-17 07:46:09 -0600 | Rating Details | |
| 2024-01-17 07:43:53 -0600 | Rating Details | |
| 2024-01-17 07:42:28 -0600 | Rating Details | |
| 2024-01-17 07:37:15 -0600 | Rating Details | |
| 2024-01-17 07:37:12 -0600 | Rating Details | |
| 2024-01-17 07:37:04 -0600 | Rating Details | |
| 2024-01-17 07:35:10 -0600 | Rating Details | |
| 2024-01-17 07:33:14 -0600 | Rating Details | |
| 2024-01-17 07:32:47 -0600 | Rating Details | |
| 2024-01-17 07:30:17 -0600 | Rating Details | |
| 2024-01-17 07:30:12 -0600 | Rating Details | |
| 2024-01-17 07:28:00 -0600 | Rating Details | |
| 2024-01-17 07:25:58 -0600 | Rating Details | |
| 2024-01-17 07:23:56 -0600 | Rating Details | |
| 2024-01-17 07:21:21 -0600 | Rating Details | |
| 2024-01-17 07:09:47 -0600 | Rating Details | |
| 2024-01-18 23:58:52 -0600 | Rating Details | |
| 2024-01-18 15:53:03 -0600 | Rating Details | |
| 2024-01-18 15:40:24 -0600 | Rating Details | |
| 2024-01-18 15:30:23 -0600 | Rating Details | |
| 2024-01-18 11:27:33 -0600 | Rating Details | |
| 2024-01-18 11:20:49 -0600 | Rating Details | |
| 2024-01-18 11:20:03 -0600 | Rating Details | |
| 2024-01-18 11:12:34 -0600 | Rating Details | |
| 2024-01-19 10:44:49 -0600 | Rating Details | |
| 2024-01-20 00:52:07 -0600 | Rating Details | |
| 2024-01-18 16:36:49 -0600 | Rating Details | |
| 2024-01-18 15:32:37 -0600 | Rating Details | |
| 2024-01-18 14:21:12 -0600 | Rating Details | |
| 2024-01-18 14:03:32 -0600 | Rating Details | |
| 2024-01-18 12:05:37 -0600 | Rating Details | |
| 2024-01-18 11:48:16 -0600 | Rating Details | |
| 2024-01-18 05:55:30 -0600 | Rating Details | |
| 2024-01-18 02:21:50 -0600 | Rating Details | |
| 2024-01-17 21:12:12 -0600 | Rating Details | |
| 2024-01-17 20:19:25 -0600 | Rating Details | |
| 2024-01-17 18:59:17 -0600 | Rating Details | |
| 2024-01-17 15:50:23 -0600 | Rating Details | |
| 2024-01-17 15:01:29 -0600 | Rating Details | |
| 2024-01-17 15:00:54 -0600 | Rating Details | |
| 2024-01-17 14:42:57 -0600 | Rating Details | |
| 2024-01-17 14:35:57 -0600 | Rating Details | |
| 2024-01-17 11:56:29 -0600 | Rating Details | |
| 2024-01-17 11:45:19 -0600 | Rating Details | |
| 2024-01-17 08:56:37 -0600 | Rating Details | |
| 2024-01-17 08:36:41 -0600 | Rating Details | |
| 2024-01-17 08:29:11 -0600 | Rating Details | |
| 2024-01-17 08:22:24 -0600 | Rating Details | |
| 2024-01-17 08:16:19 -0600 | Rating Details | |
| 2024-01-17 08:14:44 -0600 | Rating Details | |
| 2024-01-17 08:10:47 -0600 | Rating Details | |
| 2024-01-17 08:07:27 -0600 | Rating Details | |
| 2024-01-17 08:05:38 -0600 | Rating Details | |
| 2024-01-17 07:54:53 -0600 | Rating Details | |
| 2024-01-17 07:54:37 -0600 | Rating Details | |
| 2024-01-17 07:53:26 -0600 | Rating Details | |
| 2024-01-17 07:51:24 -0600 | Rating Details | |
| 2024-01-17 07:46:18 -0600 | Rating Details | |
| 2024-01-17 07:34:06 -0600 | Rating Details | |
| 2024-01-17 07:29:35 -0600 | Rating Details | |
| 2024-01-17 07:20:18 -0600 | Rating Details | |
| 2024-01-21 21:48:55 -0600 | Rating Details | |
| 2024-01-18 15:46:41 -0600 | Rating Details | |
| 2024-01-18 13:42:03 -0600 | Rating Details | |
| 2024-01-17 14:40:04 -0600 | Rating Details | |
| 2024-01-22 07:23:51 -0600 | Rating Details |